In several models of lymphocyte apoptosis, two alterations of mitochondrial function precede advanced DNA fragmentation: (1) a reduction of mitochondrial transmembrane potential (A@,) and (2) an increase in mitochondrial generation of superoxide anion. Here we show that two fluorochromes allow for the identification of analogous mitochondrial perturbations in circulating T lymphocytes from human immunodeficiency virus (HIV)-l+ donors. The first among these fluorochromes, the cationic lipophilic dye DiOCe(3), measures A @ , ; the second marker, hydroethidine (HE), is nonfluorescent, unless it is oxidized by superoxide anions to the product ethidium (Eth). CD4+ or CD8' cells from clinically asymptomatic HIV-1 carriers contain a significantly elevated percentage of cells endowed with enhanced HE + Eth conversion and/or reduced DiOG(3) uptake as compared with normal controls. Phenotypic characterization of (HE -+ EthIhbh cells from HIV' donors shows that these T IS GENERALLY assumed that apoptosis or programmed cell death (PCD) is the mechanism by which superfluous or damaged cells are removed in most organ systems. This applies to organogenesis, the maintenance of the status quo in normal tissues, responses to light (subnecrotic) chemical or physical damage, as well as acquired immunodeficiency syndrome (AIDS) pathogenesis. The advanced stage of PCD is marked by characteristic alterations of nuclear morphology and a step-wise degradation of chromosomal DNA.'.' Accordingly, current techniques for the detection of apoptotic cells are based on the assessment of DNA breaks that create potential acceptor sites for DNA polymerase or terminal desoxyribonucleotidyltransferase.3~4 However, even during treatments that cause massive cell depletion in vivo and are known to cause apoptosis in vitro, end-stage apoptosis is difficult to be detected in freshly isolated peripheral lymphocytes from the spleen, lymph nodes, or the circ~lation.~.~-~ This phenomenon can be attributed to the sequestration' or phagocytic removal of cells undergoing apoptosis in vivo." To show DNA alterations indicative of apoptosis in peripheral lymphocytes, it is indispensable to culture cells during a few hours in vitro. This has been demonstrated for mice treated with lymphocyte-depleting doses of glucocorticoids,' super antigen^,^ or peptide antigen: for patients treated with cytostatic drugs,6 for patients with spontaneous tumor remissions,8 as well as for human immunodeficiency virus (HIV)-infected donors.3*"
We have recently shown that thymocytes or lymphocytes exposed to apoptosis-inducing doses of glucocorticoids demonstrate a step-wise dysregulation of mitochondrial function that precedes signs of nuclear apoptosis. Cells sequentially exhibit a first reduction of the mitochondrial transmembrane potential (AV!,,,), as quantifiable by means of suitable fluorochromes [DiOC6(3), JC-l, rhodamine 1231, and then an additional decrease in AV!,,, accompanied by an increased superoxide anion-mediated oxidation of hydroethidine (HE) into the fluorescent product ethidium (Eth).""4 Disruption of At least a fraction of cells with low A s , is irreversibly committed to undergo DNA fragmentation, as shown by experiments in which glucocorticoid-primed AV!:w cells with yet-intact DNA were purified and cultured in vitro, after withdrawal of the apoptosis-inducing stimulus by means of a glucocorticoid receptor antagonist." These data underline the notion that nuclear alterations accompanying apoptosis are relatively late events of the apoptotic cascade15 and that a cytoplasmic (mitochondrial?) control instance can dictate the fate of the Stimulated by these observations, we have tested whether perturbations of mitochondrial structure or function might occur among circulating T lymphocytes from individuals infected with HIV-l. Here we show that circulating lymphocytes from HIV-infected donors are characterized by a decreased A@, andor enhanced mitochondrial reactive oxygen species (ROS) generation, suggesting that HIV-triggered apoptotic lymphocyte depletion obeys the same rules as physiologic PCD. These insights are important for the comprehension of HIV-mediated lymphocyte depletion, as well as for the direct quantitative evaluation of ongoing PCD in AIDS. 
MATERIALS AND METHODS
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Noninfected healthy controls exhibited the following characteristics: 24 to 65 years of age (37 ? 14, n = 11); 22.5% to 48.4% (38.3% 2 6.8%) CD4+ and 30.0% to 80.5% (56.3% t 12.9%) CD8+ lymphocytes. Blood was collected in EDTA tubes and kept on ice until cell preparation and analysis. PBMC were prepared using Ficoll Hypaque (Phannacia, Uppsala, Sweden) and maintained in complete culture medium at 4°C until labeling. In addition, aliquots of cells were cultured overnight at 37°C as described.'
Cytojluorometric analysis and functional tests in vitro. For the simultaneous assessment of surface markers and mitcchondrial ROS generation, cells were first stained with phycoerythrine (PE)-labeled anti-hCD4 (13B8.2) or anti-hCD8a (B9.11; Immunotech, Marseille, France) antibodies (30 minutes on ice). Cells were washed (5 minutes; 600g; 4°C) in ice-cold staining buffer (phosphate-buffered saline [PBS], pH = 7.2, supplemented with 2% bovine serum albumin [BSA]) followed by exposure during 15 minutes at 37°C to hydroethidine (HE; 2 pmoVL; Molecular Probes, Eugene, 0R).I8 For the simultaneous determination of one surface marker and mitochondrial ROS generation, as well as As,, cells were first stained with PElabeled antibodies and then exposed to DiOCa(3) (3,3'-dihexyloxacarbocyanine iodide; 40 nmoE, Molecular Probes)'' and HE (2 pmoVL; 3 7 T , 15 minutes).I8 In control experiments, cells were labeled after preincubation with the uncoupling agent carbonyl cyanide m-chlorophenylhydrazone (mClCCP; 50 pmoVL, 37"C, 30 minutes; Sigma, St Louis, MO), menadione (1 mmollL, 37°C. 1 hour; Sigma), or rotenone (1 mmom, 37"C, 30 minutes; Sigma). In some tests, HE labeling was combined with 10-N nonyl-acridine orange (NAO; 100 nmoVL; 3 7 T , 15 minutes)" or 2',7'-dichlorofluorescin diacetate (DCFH-DA; 5 pmol/L; 37°C 15 minutes; Molecular Probes)?' Annexin V-FITC conjugate (250 ng/mL, 10 minutes at 4°C; Brand Application BV, Maastricht, The Netherlands) was used to detect phosphatidylserine residuesz2 exposed at the cell surface of HE-labeled cells. Analyses were performed on an Epics Profile I1 cytofluorometer (Coulter, Hialeah, E). Forward and side 
RESULTS AND DISCUSSION
T cells from HIV-infected donors exhibit a A@", decrease and enhanced ROS generation. It is widely assumed that AIDS-associated lymphopenia is the result of an enhanced apoptotic turnover of peripheral T lymphocytes."" However, circulating T lymphocytes from HIV' donors fail to exhibit signs of DNA fragmentation when analyzed directly ex vivo, and it is necessary to culture such cells in vitro to reveal nuclear signs of apoptosis.3." To resolve this dilemma, we have measured mitochondrial alterations that are associated with an early stage of the apoptotic process, as it occurs 2483 in a number of different systems of physiologic apoptosis ind~ction.""~ As shown for one representative asymptomatic HIV' donor (Fig IA) , circulating lymphocytes from HIV' donors contain a fraction of cells that are able of oxidizing the nonfluorescent lipophilic (ie, membrane-permeable) dye HE into the hydrophilic fluorescent product Eth. The percentage of such cells, which bear an (HE + Eth)hifh phenotype, is elevated when compared to noninfected controls (Fig IA) . This applies to both CD4' and CD8' T cells (Fig I , A  and B) , which are freshly isolated from peripheral blood.
Statistical analysis showed a highly significant (P S .01) difference between HIV' donors and healthy controls. In addition, we found that, irrespective of the CD4/CD8 phenotype, a relatively high percentage of peripheral blood T lymphocytes from HIV' donors incorporate low levels of DIOC6(3) (Fig 2A) , a dye that incorporates into mitochondria in strict dependence of the A@'m.13.1'.iy Again, this parameter was significantly different between HIV' donors and uninfected age-and sex-matched controls (Fig 2B) .
No correlation between the clinical status of HIV carriers and HE + Eth conversion or DIOC6(3) incorporation was observed ( Table l) (Fig 2) . These results suggest that perturbed lymphocyte metabolism is a consequence of HIV infection rather than a result of secondary infections by opportunistic microorganisms.
1) and reduced DIOC6(3) incorporation
In synthesis, circulating T lymphocytes from HIV-infected yet-asymptomatic individuals display an increase in two functionally aberrant subsets: (1) a major subset of cells that possess a low A@" and (2) a minor population that hypergenerates ROS.
Relationship between AQ,,, decrease and ROS hypergenerarion. The mean difference between HIV' and HIVgroups is less pronounced for HE "* Eth conversion (approximately 3%, Fig IB) than for DiOC6(3) staining (approximately 20%, Fig 2B) . To unravel the relationship between HE -, Eth conversion and DiOC6(3) staining, cells from controls and HIV' donors were labeled simultaneously with HE and DiOC6(3). As shown in Fig 3, all (HE + Eth)high cells possess a low AQ,,,. Thus, HIV infection is accompanied by an increase of two subpopulations of AQl];'" cells, a first population that still lacks ROS generation and a second one that hyperproduces ROS. Among these populations, the first one has the same phenotype as control cells treated with the protonophor mClCCP (inset in Fig 3) , and the second behaves like control cells exposed to menadione, a substance that causes mitochondrial ROS generation as well as AQ,,, disruption.23 Treatment of lymphocytes from HIV' donors with rotenone, an inhibitor of the respiratory chain complex I, greatly reduces labeling with HE (Fig 3) and thus confirms that the ROS responsible for HE + Eth conversion are generated in mitochondria. Accordingly, (HE "* Eth)hieh lymphocytes do not stain with DCFH-DA (Fig 3) . a fluorochrome that detects H202 formation but is not sensitive to superoxide anions.'* Therefore, the principal ROS that is produced by T cells from HIV+ donors is likely to be superoxide anion, an ROS that is preferentially produced in mitochondria and to which HE is particularly sensitive." Correlation between A@,,, decrease and nuclear signs of apoptosis in cells from HIV carriers. In a further series of experiments we attempted to correlate mitochondrial perturbations, as assessed by DiOC6(3) staining, with nuclear signs of apoptosis. When cultured during 18 hours in vitro, a significant portion of cells from HIV' individuals undergo DNA fragmentation, as detected by the incorporation of fluorescein-12-dUTP catalyzed by the enzyme terminal desoxyribonucle~tidyltransferase.~ The percentage of cells that spontaneously undergo DNA fragmentation after overnight in vitro culture correlates positively with the percentage of A Q p cells determined ex vivo (Fig 4) . As a consequence, it appears plausible that those cells which are characterized by a low A@,,, ex vivo are programmed to die from apoptosis.
As described p r e v i~u s l y~~ no correlation between nuclear apoptosis occurring after in vitro culture and progression to disease was observed (Fig 4) . As a consequence, the lack of correlation between mitochondrial parameters of apoptosis and the clinical state of patients appears to be coherent.
ROS-producing lymphocytes from H I V donors exhibit
structural alterations of membranes. To obtain information on the membrane structure of (HE " from HIV' donors, we performed double-staining experiments with two markers of membrane structure, NAO and annexin V (Fig 5) . NAO is a fluorochrome that interacts stoichiometrically with cardiolipin in the inner mitochondrial membrane, independently of the (HE "* Eth)hiFh cells exhibit a relatively weak staining with NAO, indicating that ROS hypergeneration is coupled to a structural alteration of mitochondria. Moreover, we found that a minor fraction of (HE + Eth)hieh cells, especially those with the strongest capacity of HE oxidation, bind an annexin V-FITC conju- mentation. The frequency of DiOCJ3) cells was assessed among the entire lymphocyte population ex vivo, among freshly isolated lymphocytes. In addition, aliquots of cells were cultured during 18 hours at 37°C in the absence of any external stimuli, followed by determination of DNA fragmentation using the Tunnel method.
gate. Conversely, all cells that bind annexin V are (HE "* Eth)hiCh. The cytoskeleton protein annexin V reacts with phosphatidyl serine residues that are aberrantly exposed on the outer leaflet of membranes and may serve as a marker of early apoptosis.22 Because phosphatidyl serine residues allow for the phagocytic recognition of apoptotic cells,'5 it can be speculated that (HE + Eth)hiCh annexin V+ cells represent a stage of early apoptosis that is subject to in vivo purging by the reticuloendothelial system. In conclusion, two membrane alterations affect (HE "* Eth)hiEh cells from HIV-l camers. All (HE + Eth)hiFh cells carry a defect of the inner mitochondrial membrane, whereas For personal use only. on October 27, 2017. by guest www.bloodjournal.org From a minor subset of (HE + Eth)high cells exposes phosphatidylserine residues at the surface.
CONCLUDING REMARKS
Lymphocytes undergoing physiological PCD suffer a sequential dysregulation of mitochondrial function early during the apoptotic p r o~e s s . '~"~ Cells first exhibit a strong reduction in A@,,,; then they manifest a phenotype similar to menadione-treated cells, namely a near-to-complete disruption of A@,,, accompanied by the generation of superoxide anions (Fig 3) . Here we present data suggesting that this sequence of early apoptotic changes also applies to lymphocytes derived from HIV-infected individuals (Figs I through   3 ). Thus, cytofluorometric assessment of A@., and superoxide anion production show an enhanced frequency of DiOCs(3)low and (HE + Eth)high cells among CD4' and CD8' lymphocytes from HIV+ donors when compared with agematched normal controls. These alterations are found among freshly isolated cells that still lack nuclear DNA alterations, without any need of in vitro culture.
The observation that mitochondria from HIV' lymphocytes exhibit a A@., reduction is compatible with the decrease of A@,,, caused by in vitro infection of cell lines with feline AIDS virus, a retrovirus that shares several functional and structural characteristics of HIV.26 Moreover, antioxidant inhibition of HIV-associated T-lymphocyte apoptosis in vitroz7 suggests that elevated superoxide anion production by a fraction of HIV+ lymphocytes is indeed important for lymphocyte depletion. As to the mechanism of mitochondrial alterations associated with HIV infection, two findings may be relevant. On one hand, HIV-encoded RNA has been found to selectively enrich in mitochondria of infected cells:' thereby hinting at the possibility that HIV products directly affect mitochondrial function in situ. On the other hand, HIV gene expression has been associated with a deprotection of cells from oxidative stress, namely a reduction of glutathione peroxidase activityz9 and a Tat-mediated transcriptional suppression of a mitochondrial enzyme responsible for superoxide detoxification, Mn-dependent superoxide dismutase (SOD2).30 Insufficient conversion of superoxide anions into H202 in HIV-infected cells would be compatible with the negative DCFH-DA staining of (HE -+ Eth)high cells (Fig 3) . Speculatively, deficient detoxification of superoxide anions could further enhance the vulnerability of HIV-infected cells to the apoptosis-inducing effect of endogenous ROS. However, it is premature to extrapolate these published datathat have been obtained in v i t r~~~-~~-t o lymphocyte populations recovered from HIV-infected donors ex vivo (this report). Indeed, both direct cytopathic and indirect HIV effects (gp120-CD4 interactions, self-destructive Fad FasL loops, could give rise to the apoptotic destruction of T cells. The DiOC6(3)/HE staining used in this report cannot discriminate between these possibilities. Nevertheless, the assessment of mitochondrial structure and function may allow for a direct estimation of HJV-induced lymphocyte depletion and thus may provide a useful tool for the in vivo/ex vivo evaluation of antiretroviral and/or apoptosisinhibitory treatments. Indeed, the determination of mitochondrial parameters unravels apoptosis-associated dysfunctions among circulating cells at a moment at which conventional tests addressing nuclear parameters of apoptosis fail to yield positive results.
